This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pasqualini, R., Koivunen, E., and Ruoslahti, E. 1997. Nature Biotechnology 15: 542–546.
Brooks, P.C., Clark, R.A., and Cheresh, D.A. 1994. Science 264: 569–571.
Neri, D. et al. 1997. Nature Biotechnology 15: 1271 –1275.
Winter, G, et al. 1994. Ann. Rev. Immunol. 12: 433–455.
Folkman, J. 1971. New Engl. J. Med. 285: 1182–1186.
Auerbach, W. and Auerbach R. 1994. Pharmacol. Ther. 63: 265–311.
Bicknell, R. and Harris, A.L. 1996. Current Opin. Oncol. 8: 60–65.
Huang, H. et al. 1997. Science 275: 547–550.
Folkman, J. 1997. Nature Biotechnology 15: 510.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zetter, B. On target with tumor blood vessel markers. Nat Biotechnol 15, 1243–1244 (1997). https://doi.org/10.1038/nbt1197-1243
Issue Date:
DOI: https://doi.org/10.1038/nbt1197-1243
This article is cited by
-
New studies about the insertion mechanism of Thymosin α1 in negative regions of model membranes as starting point of the bioactivity
Amino Acids (2016)
-
Anti-neovascular therapy using novel peptides homing to angiogenic vessels
Oncogene (2002)
-
Species-Crossreactive scFv Against the Tumor Stroma Marker “Fibroblast Activation Protein” Selected by Phage Display From an Immunized FAP−/− Knock-Out Mouse
Molecular Medicine (2001)
-
Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment
Nature Biotechnology (1999)